The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis-Reference-Cited by-同舟云学术

The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis

Published:2011-05-26 Issue:6 Volume:17 Page:674-684
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Dutkowski Philipp,Oberkofler Christian E.,Béchir Markus,Müllhaupt Beat,Geier Andreas,Raptis Dimitri A.,Clavien Pierre-Alain

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.22228/fullpdf

Reference37 articles.

1. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation;Cholongitas;Liver Transpl,2006

2. Liver and intestine transplantation in the United States, 1997-2006;Freeman;Am J Transplant,2008

3. Excellent liver transplant survival rates under the MELD/PELD system;Freeman;Transplant Proc,2005

4. Short-term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States;Yoo;Liver Int,2005

5. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans;Ahmad;Liver Transpl,2007

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive evaluation of the mechanism of human adipose mesenchymal stem cells ameliorating liver fibrosis by transcriptomics and metabolomics analysis;Scientific Reports;2024-08-28

2. The Development of a 3D PET Fibrous Scaffold Modified with an Umbilical Cord dECM for Liver Tissue Engineering;Polymers;2024-06-25

3. Sevelamer reverses liver fibrosis by deactivation of hepatic stellate cells;Biochemical Pharmacology;2024-04

4. A review on the application of chitosan-based polymers in liver tissue engineering;International Journal of Biological Macromolecules;2024-03

5. Technical Variant Liver Transplant Utilization for Pediatric Recipients: Equal Graft Survival to Whole Liver Transplants and Promotion of Timely Transplantation Only When Performed at High-volume Centers;Transplantation;2023-08-28